Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

This publication has 11 references indexed in Scilit:

• New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.
  Circulation, 1987
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolin
  Journal of Medicinal Chemistry, 1986
• Structure elucidation of the bioactive metabolites of ML-236B (mevastatin) isolated from dog urine.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• Microbial hydroxylation of ML-236B (compactin) Studies on microorganisms capable of 3.BETA.-hydroxylation of ML-236B.
  The Journal of Antibiotics, 1983
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
  Proceedings of the National Academy of Sciences, 1980
• Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.
  The Journal of Antibiotics, 1979
• Purification of 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver.
  Proceedings of the National Academy of Sciences, 1977
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase from rat liver. Its purification, properties, and immunochemical studies.
  Journal of Biological Chemistry, 1976
• ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
  The Journal of Antibiotics, 1976